Лаборатория структурно-функциональных исследований инновационных противоопухолевых средств
Исследуем молекулярные механизмы действия и структуру новых противоопухолевых препаратов для разработки более эффективной терапии
КОМАНДА ЛАБОРАТОРИИ
НАПРАВЛЕНИЯ ДЕЯТЕЛЬНОСТИ
-
1
Фундаментальные и прикладные исследования
Получение фундаментальных знаний о структурно-функциональном взаимодействии инновационных противоопухолевых агентов и развитие их приложений: ведение исследований в области химии, фармакологии, молекулярной биологии, онкологии и смежных дисциплинах
-
2
Сотрудничество и привлечение специалистов
Развитие сотрудничества с другими организациями в сфере компетенций лаборатории и подразделениями МФТИ, привлечение к выполнению исследований и разработок высококвалифицированных и перспективных специалистов
-
3
Участие в образовательном процессе
Вовлечение студентов и аспирантов в исследовательские проекты на базе лаборатории и ее партнеров, в том числе организация научного руководства выпускными квалификационными работами студентов и аспирантов
-
4
Коммуникации и популяризация науки
Представление результатов научно-исследовательской деятельности на научных конференциях и иных мероприятиях, участие в подготовке научно-популярных публикаций о работе лаборатории
НАУЧНЫЕ ИНТЕРЕСЫ И ОБЛАСТИ РАБОТЫ
Нейробиология и нейрофармакология
- Нейробиология
- Нейрофармакология
- Модель стресс-реакции у Danio rerio
- Лекарственная терапия ЦНС (Danio rerio)
- Физиология Danio rerio
Биоскрининг, диагностика и онкология
- Биоскрининг
- Диагностика
- Онкология / раковые заболевания
- Скрининг противораковых препаратов
- Тестирование новых биомолекул и препаратов
Проведение доклинических исследований
- Животные модели
- Маркеры старения
- Организация и проведение доклинических испытаний
- Разработка новых биомедицинских технологий
Клеточные технологии и 3D-модели
- Молекулярные и клеточные технологии
- 3D клеточные модели
- 3D клеточные культуры тканей: валидация, доклинические испытания
- Разработка предсказательной 3D-модели для подбора терапии
- Параллельный скрининг на клеточных моделях
Новости ЛАБОРАТОРИИ
КОНТАКТНАЯ ИНФОРМАЦИЯ
ПОЧТА
fb.institute@mipt.ru
ssbc@mipt.ru — кафедра
ТЕЛЕФОН
+7 (981) 342 12 14
СОЦИАЛЬНЫЕ СЕТИ
fb.institute@mipt.ru
ssbc@mipt.ru — кафедра
ТЕЛЕФОН
+7 (981) 342 12 14
СОЦИАЛЬНЫЕ СЕТИ
Нажимая на кнопку, вы даете согласие на обработку персональных данных и соглашаетесь c политикой конфиденциальности
АДРЕС
Московская область, город Долгопрудный, Институтский переулок, д. 9, стр. 7, корпус «Физтех.БИО»
Московская область, город Долгопрудный, Институтский переулок, д. 9, стр. 7, корпус «Физтех.БИО»
Навигация
© 2001-2025 Московский физико-технический институт (национальный исследовательский университет)
+7 (981) 342 12 14
Социальные сети
Телефон
Почта
Новые возможности для управления здоровьем человека
Основные публикации
Modelling anti-estrogen resistance in estrogen receptor-positive breast cancer: molecular mechanisms and emerging therapeutic strategies
R Hamama, AY Alasheev, EV Petersen, PY Maximov
Oncologie 28 (1), 59−70, 2026
A Statistically Rigorous Multi-Scale Texture Analysis Framework for 3D Spheroid Characterization: Temporal Autocorrelation Correction and Molecular Validation
DG Regassa, MS Babaev, EY Shabalina, PY Maximov, EV Petersen, 2026
Selectivity analysis of CDK2 inhibitors via molecular dynamics of CDK1 and CDK2
DO Shkil, AS Fokina, DT Asainov, EV Petersen, AA Ivashchenko, PY Maximov
Journal of Molecular Graphics and Modelling, 109 266, 2026
Lack of interactions of SERMs with Asp351 and Phe404 of the oestrogen receptor alpha correlates with endometrial cancer development in patients
DO Shkil, AY Alasheev, AA Ivashchenko, AA Ivashchenko, PY Maximov
Molecular Simulation 51 (5), 311−327, 2025
R Hamama, AY Alasheev, EV Petersen, PY Maximov
Oncologie 28 (1), 59−70, 2026
A Statistically Rigorous Multi-Scale Texture Analysis Framework for 3D Spheroid Characterization: Temporal Autocorrelation Correction and Molecular Validation
DG Regassa, MS Babaev, EY Shabalina, PY Maximov, EV Petersen, 2026
Selectivity analysis of CDK2 inhibitors via molecular dynamics of CDK1 and CDK2
DO Shkil, AS Fokina, DT Asainov, EV Petersen, AA Ivashchenko, PY Maximov
Journal of Molecular Graphics and Modelling, 109 266, 2026
Lack of interactions of SERMs with Asp351 and Phe404 of the oestrogen receptor alpha correlates with endometrial cancer development in patients
DO Shkil, AY Alasheev, AA Ivashchenko, AA Ivashchenko, PY Maximov
Molecular Simulation 51 (5), 311−327, 2025
Основные публикации
V. O. Shipunova, E. N. Komedchikova, P. A. Kotelnikova, I. V. Zelepukin, A. A. Schulga, G. M. Proshkina, E. I. Shramova, H. L. Kutscher, G. B. Telegin, A. V. Kabashin, P. N. Prasad, and S. M. Deyev. Dual Regioselective Targeting the Same Receptor in Nanoparticle-Mediated Combination Immuno/Chemotherapy for Enhanced Image-Guided Cancer Treatment. ACS Nano Article ASAP (Q1) — 2020. DOI: 10.1021/acsnano.0c03421.
Shipunova VO, Belova MM, Kotelnikova PA, Shilova ON, Mirkasymov AB, Danilova NV, Komedchikova EN, Popovtzer R, Deyev SM, Nikitin MP. Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission. Pharmaceutics (Q1). 2022; 14(5):1013. doi.org/10.3390/pharmaceutics14051013.
Obozina, A. S., Komedchikova, E. N., Kolesnikova, O. A., Iureva, A. M., Kovalenko, V. L., Zavalko, F. A., Rozhnikova, T.V., Tereshina, E. D., Mochalova E. N., Shipunova, V. O. (2023). Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics (Q1), 15(1), 231. DOI: 10.3390/pharmaceutics15010231.
Kovalenko, V. L., Komedchikova, E. N., Sogomonyan, A. S., Tereshina, E. D., Kolesnikova, O. A., Mirkasymov, A. B., Iureva, A. M., Zvyagin A.V., Nikitin P.I., Shipunova, V. O. (2023). Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo. Pharmaceutics (Q1), 15(1), 92. DOI: 10.3390/pharmaceutics15010092.
Komedchikova, E. N., Kolesnikova, O. A., Tereshina, E. D., Kotelnikova, P. A., Sogomonyan, A. S., Stepanov, A. V., Deyev S.M., Nikitin M.P., Shipunova, V. O. (2023). Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells. Pharmaceutics (Q1), 15(1), 52. DOI: 10.3390/pharmaceutics15010052.
Drozdov, A. S., Komarova, K. S., Mochalova, E. N., Komedchikova, E. N., Shipunova, V. O., & Nikitin, M. P. (2023). Fluorescent Magnetic Nanoparticles for Bioimaging through Biomimetic Surface Modification. International Journal of Molecular Sciences (Q1), 24(1), 134. DOI: 10.3390/ijms24010134.
Kovalenko, V.L.; Kolesnikova, O.A.; Nikitin, M.P.; Shipunova, V.O.; Komedchikova, E.N. Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents. Micromachines (Q2) 2023, 14, 1647. doi.org/10.3390/mi14081647.
Shipunova, V.O.; Komedchikova, E.N.; Kotelnikova, P.A.; Nikitin, M.P.; Deyev, S.M. Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy. Pharmaceutics (Q1) 2023, 15, 833. doi.org/10.3390/pharmaceutics15030833.
Komedchikova EN, Kolesnikova OA, Syuy AV, Volkov VS, Deyev SM, Nikitin MP, Shipunova VO. Targosomes: Anti-HER2 PLGA nanocarriers for bioimaging, chemotherapy and local photothermal treatment of tumors and remote metastases. J Control Release (Q1). 2023 Nov 25; 365:317−330. doi: 10.1016/j.jconrel.2023.11.036.
Shipunova VO, Belova MM, Kotelnikova PA, Shilova ON, Mirkasymov AB, Danilova NV, Komedchikova EN, Popovtzer R, Deyev SM, Nikitin MP. Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission. Pharmaceutics (Q1). 2022; 14(5):1013. doi.org/10.3390/pharmaceutics14051013.
Obozina, A. S., Komedchikova, E. N., Kolesnikova, O. A., Iureva, A. M., Kovalenko, V. L., Zavalko, F. A., Rozhnikova, T.V., Tereshina, E. D., Mochalova E. N., Shipunova, V. O. (2023). Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics (Q1), 15(1), 231. DOI: 10.3390/pharmaceutics15010231.
Kovalenko, V. L., Komedchikova, E. N., Sogomonyan, A. S., Tereshina, E. D., Kolesnikova, O. A., Mirkasymov, A. B., Iureva, A. M., Zvyagin A.V., Nikitin P.I., Shipunova, V. O. (2023). Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo. Pharmaceutics (Q1), 15(1), 92. DOI: 10.3390/pharmaceutics15010092.
Komedchikova, E. N., Kolesnikova, O. A., Tereshina, E. D., Kotelnikova, P. A., Sogomonyan, A. S., Stepanov, A. V., Deyev S.M., Nikitin M.P., Shipunova, V. O. (2023). Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells. Pharmaceutics (Q1), 15(1), 52. DOI: 10.3390/pharmaceutics15010052.
Drozdov, A. S., Komarova, K. S., Mochalova, E. N., Komedchikova, E. N., Shipunova, V. O., & Nikitin, M. P. (2023). Fluorescent Magnetic Nanoparticles for Bioimaging through Biomimetic Surface Modification. International Journal of Molecular Sciences (Q1), 24(1), 134. DOI: 10.3390/ijms24010134.
Kovalenko, V.L.; Kolesnikova, O.A.; Nikitin, M.P.; Shipunova, V.O.; Komedchikova, E.N. Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents. Micromachines (Q2) 2023, 14, 1647. doi.org/10.3390/mi14081647.
Shipunova, V.O.; Komedchikova, E.N.; Kotelnikova, P.A.; Nikitin, M.P.; Deyev, S.M. Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy. Pharmaceutics (Q1) 2023, 15, 833. doi.org/10.3390/pharmaceutics15030833.
Komedchikova EN, Kolesnikova OA, Syuy AV, Volkov VS, Deyev SM, Nikitin MP, Shipunova VO. Targosomes: Anti-HER2 PLGA nanocarriers for bioimaging, chemotherapy and local photothermal treatment of tumors and remote metastases. J Control Release (Q1). 2023 Nov 25; 365:317−330. doi: 10.1016/j.jconrel.2023.11.036.
Основные публикации
Shipunova VO, Kolesnikova OA, Kotelnikova PA, Soloviev VD, Popov AA, Proshkina GM, Nikitin MP, Deyev SM. Comparative Evaluation of Engineered Polypeptide Scaffolds in HER2-Targeting Magnetic Nanocarrier Delivery. ACS Omega. 2021 Jun 10;6(24):16 000−16 008. doi: 10.1021/acsomega.1c01811. IF 4.1, Q1.
Kovalenko VL, Kolesnikova OA, Nikitin MP, Shipunova VO, Komedchikova EN. Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents. Micromachines (Basel). 2023 Aug 21;14(8):1647. doi: 10.3390/mi14081647. IF 3.4, Q2.
Obozina AS, Komedchikova EN, Kolesnikova OA, Iureva AM, Kovalenko VL, Zavalko FA, Rozhnikova TV, Tereshina ED, Mochalova EN, Shipunova VO. Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics. 2023 Jan 10;15(1):231. doi: 10.3390/pharmaceutics15010231. IF 5.4, Q1.
Komedchikova EN, Kolesnikova OA, Tereshina ED, Kotelnikova PA, Sogomonyan AS, Stepanov AV, Deyev SM, Nikitin MP, Shipunova VO. Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells. Pharmaceutics. 2022 Dec 24;15(1):52. doi: 10.3390/pharmaceutics15010052. IF 5.4, Q1.
Kovalenko VL, Komedchikova EN, Sogomonyan AS, Tereshina ED, Kolesnikova OA, Mirkasymov AB, Iureva AM, Zvyagin AV, Nikitin PI, Shipunova VO. Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo. Pharmaceutics. 2022 Dec 27;15(1):92. doi: 10.3390/pharmaceutics15010092. IF 5.4, Q1.
Komedchikova EN, Kolesnikova OA, Syuy AV, Volkov VS, Deyev SM, Nikitin MP, Shipunova VO. Targosomes: Anti-HER2 PLGA nanocarriers for bioimaging, chemotherapy and local photothermal treatment of tumors and remote metastases. J Control Release. 2024 Jan;365:317−330. doi: 10.1016/j.jconrel.2023.11.036. Epub 2023 Nov 25. PMID: 37 996 056. IF 10.8, Q1.
Kovalenko, V.L.; Kolesnikova, O.A.; Nikitin, M.P.; Shipunova, V.O.; Komedchikova, E.N. Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents. Micromachines (Q2) 2023, 14, 1647. doi.org/10.3390/mi14081647.
Shipunova, V.O.; Komedchikova, E.N.; Kotelnikova, P.A.; Nikitin, M.P.; Deyev, S.M. Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy. Pharmaceutics (Q1) 2023, 15, 833. doi.org/10.3390/pharmaceutics15030833.
Komedchikova EN, Kolesnikova OA, Syuy AV, Volkov VS, Deyev SM, Nikitin MP, Shipunova VO. Targosomes: Anti-HER2 PLGA nanocarriers for bioimaging, chemotherapy and local photothermal treatment of tumors and remote metastases. J Control Release (Q1). 2023 Nov 25; 365:317−330. doi: 10.1016/j.jconrel.2023.11.036.
Kovalenko VL, Kolesnikova OA, Nikitin MP, Shipunova VO, Komedchikova EN. Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents. Micromachines (Basel). 2023 Aug 21;14(8):1647. doi: 10.3390/mi14081647. IF 3.4, Q2.
Obozina AS, Komedchikova EN, Kolesnikova OA, Iureva AM, Kovalenko VL, Zavalko FA, Rozhnikova TV, Tereshina ED, Mochalova EN, Shipunova VO. Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics. 2023 Jan 10;15(1):231. doi: 10.3390/pharmaceutics15010231. IF 5.4, Q1.
Komedchikova EN, Kolesnikova OA, Tereshina ED, Kotelnikova PA, Sogomonyan AS, Stepanov AV, Deyev SM, Nikitin MP, Shipunova VO. Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells. Pharmaceutics. 2022 Dec 24;15(1):52. doi: 10.3390/pharmaceutics15010052. IF 5.4, Q1.
Kovalenko VL, Komedchikova EN, Sogomonyan AS, Tereshina ED, Kolesnikova OA, Mirkasymov AB, Iureva AM, Zvyagin AV, Nikitin PI, Shipunova VO. Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo. Pharmaceutics. 2022 Dec 27;15(1):92. doi: 10.3390/pharmaceutics15010092. IF 5.4, Q1.
Komedchikova EN, Kolesnikova OA, Syuy AV, Volkov VS, Deyev SM, Nikitin MP, Shipunova VO. Targosomes: Anti-HER2 PLGA nanocarriers for bioimaging, chemotherapy and local photothermal treatment of tumors and remote metastases. J Control Release. 2024 Jan;365:317−330. doi: 10.1016/j.jconrel.2023.11.036. Epub 2023 Nov 25. PMID: 37 996 056. IF 10.8, Q1.
Kovalenko, V.L.; Kolesnikova, O.A.; Nikitin, M.P.; Shipunova, V.O.; Komedchikova, E.N. Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents. Micromachines (Q2) 2023, 14, 1647. doi.org/10.3390/mi14081647.
Shipunova, V.O.; Komedchikova, E.N.; Kotelnikova, P.A.; Nikitin, M.P.; Deyev, S.M. Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy. Pharmaceutics (Q1) 2023, 15, 833. doi.org/10.3390/pharmaceutics15030833.
Komedchikova EN, Kolesnikova OA, Syuy AV, Volkov VS, Deyev SM, Nikitin MP, Shipunova VO. Targosomes: Anti-HER2 PLGA nanocarriers for bioimaging, chemotherapy and local photothermal treatment of tumors and remote metastases. J Control Release (Q1). 2023 Nov 25; 365:317−330. doi: 10.1016/j.jconrel.2023.11.036.
Основные публикации
Obozina, A.S.; Komedchikova, E.N.; Kolesnikova, O.A.; Iureva, A.M.; Kovalenko, V.L.; Zavalko, F.A.; Rozhnikova, T.V.; Tereshina, E.D.; Mochalova, E.N.; Shipunova, V.O. Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics 2023, 15, 231. doi.org/10.3390/pharmaceutics15010231.
Основные публикации
Iureva et al. The influence of various polymer coatings on the in vitro and in vivo properties of PLGA nanoparticles: Comprehensive study // European Journal of Pharmaceutics and Biopharmaceutics. — 2024. — С. 114 366.
Kovalenko V. L. et al. Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo //Pharmaceutics. — 2022. — Т. 15. — №. 1. — С. 92.
Obozina A. S. et al. Genetically encoded self-assembling protein nanoparticles for the targeted delivery in vitro and in vivo //Pharmaceutics. — 2023. — Т. 15. — №. 1. — С. 231.
Kotelnikova P. A. et al. Peroxidase-like activity of silver nanowires and its application for colorimetric detection of the antibiotic chloramphenicol //Talanta Open. — 2022. — Т. 6. — С. 100 164.
Kovalenko V. L. et al. Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo //Pharmaceutics. — 2022. — Т. 15. — №. 1. — С. 92.
Obozina A. S. et al. Genetically encoded self-assembling protein nanoparticles for the targeted delivery in vitro and in vivo //Pharmaceutics. — 2023. — Т. 15. — №. 1. — С. 231.
Kotelnikova P. A. et al. Peroxidase-like activity of silver nanowires and its application for colorimetric detection of the antibiotic chloramphenicol //Talanta Open. — 2022. — Т. 6. — С. 100 164.
Основные публикации
Optical clearing of tissues: issues of antimicrobial phototherapy and drug delivery. VV Tuchin, EA Genina, ES Tuchina, AV Svetlakova, YI Svenskaya, Advanced Drug Delivery Reviews.
Исследование фотокаталитической антимикробной активности нанокомпозитов на основе TiO–AlO при воздействии светодиодного излучения. АВ Светлакова, ЕС Тучина, АН Ходан, ВВ Тучин, Оптика и спектроскопия.
Новые гипс-титановые композиты для антимикробного фотокаталитического воздействия на Staphylococcus aureus, Е Тучина, МВ Корченова, АВ Светлакова, К Криштиану, ВВ Тучин, Известия Саратовского университета. Новая серия.
Исследование фотокаталитической антимикробной активности нанокомпозитов на основе TiO–AlO при воздействии светодиодного излучения. АВ Светлакова, ЕС Тучина, АН Ходан, ВВ Тучин, Оптика и спектроскопия.
Новые гипс-титановые композиты для антимикробного фотокаталитического воздействия на Staphylococcus aureus, Е Тучина, МВ Корченова, АВ Светлакова, К Криштиану, ВВ Тучин, Известия Саратовского университета. Новая серия.
Основные публикации
Shipunova, V.O.; Kovalenko, V.L.; Kotelnikova, P.A.; Sogomonyan, A.S.; Shilova, O.N.; Komedchikova, E.N.; Zvyagin, A.V.; Nikitin, M.P.; Deyev, S.M. Targeting Cancer Cell Tight Junctions Enhances PLGA-Based Photothermal Sensitizers’ Performance In Vitro and In Vivo. Pharmaceutics 2022, 14, 43. https://doi.org/10.3390/pharmaceutics14010043.
Obozina, A.S.; Komedchikova, E.N.; Kolesnikova, O.A.; Iureva, A.M.; Kovalenko, V.L.; Zavalko, F.A.; Rozhnikova, T.V.; Tereshina, E.D.; Mochalova, E.N.; Shipunova, V.O. Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics 2023, 15, 231. https://doi.org/10.3390/pharmaceutics15010231.
Kovalenko, V.L.; Komedchikova, E.N.; Sogomonyan, A.S.; Tereshina, E.D.; Kolesnikova, O.A.; Mirkasymov, A.B.; Iureva, A.M.; Zvyagin, A.V.; Nikitin, P.I.; Shipunova, V.O. Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo. Pharmaceutics 2023, 15, 92. https://doi.org/10.3390/pharmaceutics15010092.
Kovalenko, V.L.; Kolesnikova, O.A.; Nikitin, M.P.; Shipunova, V.O.; Komedchikova, E.N. Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents. Micromachines 2023, 14, 1647. https://doi.org/10.3390/mi14081647.
Obozina, A.S.; Komedchikova, E.N.; Kolesnikova, O.A.; Iureva, A.M.; Kovalenko, V.L.; Zavalko, F.A.; Rozhnikova, T.V.; Tereshina, E.D.; Mochalova, E.N.; Shipunova, V.O. Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics 2023, 15, 231. https://doi.org/10.3390/pharmaceutics15010231.
Kovalenko, V.L.; Komedchikova, E.N.; Sogomonyan, A.S.; Tereshina, E.D.; Kolesnikova, O.A.; Mirkasymov, A.B.; Iureva, A.M.; Zvyagin, A.V.; Nikitin, P.I.; Shipunova, V.O. Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo. Pharmaceutics 2023, 15, 92. https://doi.org/10.3390/pharmaceutics15010092.
Kovalenko, V.L.; Kolesnikova, O.A.; Nikitin, M.P.; Shipunova, V.O.; Komedchikova, E.N. Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents. Micromachines 2023, 14, 1647. https://doi.org/10.3390/mi14081647.
Основные публикации
Shipunova, V.O.; Kovalenko, V.L.; Kotelnikova, P.A.; Sogomonyan, A.S.; Shilova, O.N.; Komedchikova, E.N.; Zvyagin, A.V.; Nikitin, M.P.; Deyev, S.M. Targeting Cancer Cell Tight Junctions Enhances PLGA-Based Photothermal Sensitizers’ Performance In Vitro and In Vivo. Pharmaceutics 2022, 14, 43. https://doi.org/10.3390/pharmaceutics14010043.
Obozina, A.S.; Komedchikova, E.N.; Kolesnikova, O.A.; Iureva, A.M.; Kovalenko, V.L.; Zavalko, F.A.; Rozhnikova, T.V.; Tereshina, E.D.; Mochalova, E.N.; Shipunova, V.O. Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics 2023, 15, 231. https://doi.org/10.3390/pharmaceutics15010231.
Kovalenko, V.L.; Komedchikova, E.N.; Sogomonyan, A.S.; Tereshina, E.D.; Kolesnikova, O.A.; Mirkasymov, A.B.; Iureva, A.M.; Zvyagin, A.V.; Nikitin, P.I.; Shipunova, V.O. Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo. Pharmaceutics 2023, 15, 92. https://doi.org/10.3390/pharmaceutics15010092.
Kovalenko, V.L.; Kolesnikova, O.A.; Nikitin, M.P.; Shipunova, V.O.; Komedchikova, E.N. Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents. Micromachines 2023, 14, 1647. https://doi.org/10.3390/mi14081647.
Obozina, A.S.; Komedchikova, E.N.; Kolesnikova, O.A.; Iureva, A.M.; Kovalenko, V.L.; Zavalko, F.A.; Rozhnikova, T.V.; Tereshina, E.D.; Mochalova, E.N.; Shipunova, V.O. Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics 2023, 15, 231. https://doi.org/10.3390/pharmaceutics15010231.
Kovalenko, V.L.; Komedchikova, E.N.; Sogomonyan, A.S.; Tereshina, E.D.; Kolesnikova, O.A.; Mirkasymov, A.B.; Iureva, A.M.; Zvyagin, A.V.; Nikitin, P.I.; Shipunova, V.O. Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo. Pharmaceutics 2023, 15, 92. https://doi.org/10.3390/pharmaceutics15010092.
Kovalenko, V.L.; Kolesnikova, O.A.; Nikitin, M.P.; Shipunova, V.O.; Komedchikova, E.N. Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents. Micromachines 2023, 14, 1647. https://doi.org/10.3390/mi14081647.
Основные публикации
Shipunova, V.O.; Kovalenko, V.L.; Kotelnikova, P.A.; Sogomonyan, A.S.; Shilova, O.N.; Komedchikova, E.N.; Zvyagin, A.V.; Nikitin, M.P.; Deyev, S.M. Targeting Cancer Cell Tight Junctions Enhances PLGA-Based Photothermal Sensitizers’ Performance In Vitro and In Vivo. Pharmaceutics 2022, 14, 43. https://doi.org/10.3390/pharmaceutics14010043.
Obozina, A.S.; Komedchikova, E.N.; Kolesnikova, O.A.; Iureva, A.M.; Kovalenko, V.L.; Zavalko, F.A.; Rozhnikova, T.V.; Tereshina, E.D.; Mochalova, E.N.; Shipunova, V.O. Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics 2023, 15, 231. https://doi.org/10.3390/pharmaceutics15010231.
Kovalenko, V.L.; Komedchikova, E.N.; Sogomonyan, A.S.; Tereshina, E.D.; Kolesnikova, O.A.; Mirkasymov, A.B.; Iureva, A.M.; Zvyagin, A.V.; Nikitin, P.I.; Shipunova, V.O. Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo. Pharmaceutics 2023, 15, 92. https://doi.org/10.3390/pharmaceutics15010092.
Kovalenko, V.L.; Kolesnikova, O.A.; Nikitin, M.P.; Shipunova, V.O.; Komedchikova, E.N. Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents. Micromachines 2023, 14, 1647. https://doi.org/10.3390/mi14081647.
Obozina, A.S.; Komedchikova, E.N.; Kolesnikova, O.A.; Iureva, A.M.; Kovalenko, V.L.; Zavalko, F.A.; Rozhnikova, T.V.; Tereshina, E.D.; Mochalova, E.N.; Shipunova, V.O. Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics 2023, 15, 231. https://doi.org/10.3390/pharmaceutics15010231.
Kovalenko, V.L.; Komedchikova, E.N.; Sogomonyan, A.S.; Tereshina, E.D.; Kolesnikova, O.A.; Mirkasymov, A.B.; Iureva, A.M.; Zvyagin, A.V.; Nikitin, P.I.; Shipunova, V.O. Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo. Pharmaceutics 2023, 15, 92. https://doi.org/10.3390/pharmaceutics15010092.
Kovalenko, V.L.; Kolesnikova, O.A.; Nikitin, M.P.; Shipunova, V.O.; Komedchikova, E.N. Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents. Micromachines 2023, 14, 1647. https://doi.org/10.3390/mi14081647.
Заполните эту форму
Мы обязательно с Вами свяжемся